International Flavors & Fragrances Inc. (BIT:1IFF)
Italy
· Delayed Price · Currency is EUR 58.36
+2.76 (4.96%)
At close: Dec 4, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Nourish Revenue | - | 5.87B |
Log In |
Log In |
Log In | Upgrade
|
| Health & Biosciences Revenue | 2.25B | 2.21B |
Log In |
Log In |
Log In | Upgrade
|
| Scent Revenue | 2.45B | 2.44B |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Solutions Revenue | - | 961.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 6.38B | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 11.07B | 11.48B |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBITDA
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Nourish Adjusted Operating EBITDA | - | 824.00M |
Log In |
Log In |
Log In | Upgrade
|
| Health & Biosciences Adjusted Operating EBITDA | 596.00M | 654.00M |
Log In |
Log In |
Log In | Upgrade
|
| Scent Adjusted Operating EBITDA | 506.00M | 518.00M |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Solutions Adjusted Operating EBITDA | - | 209.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -1.45B | -1.45B |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | -351.00M | 755.00M |
Log In |
Log In |
Log In | Upgrade
|
Capital Expenditures
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 |
| Nourish Capital Expenditures | 235.00M |
Log In |
Log In |
Log In | Upgrade
|
| Health & Biosciences Capital Expenditures | 73.00M |
Log In |
Log In |
Log In | Upgrade
|
| Scent Capital Expenditures | 70.00M |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Solutions Capital Expenditures | 85.00M |
Log In |
Log In |
Log In | Upgrade
|